✦ LIBER ✦

Current and Future Therapies for the Medical Management of Secondary Hyperparathyroidism

✍ Scribed by Glenn M. Chertow; Kevin J. Martin

Book ID: 109082390
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 468 KB
Volume: 11
Category: Article
ISSN: 0894-0959
DOI: 10.1111/j.1525-139x.1998.tb00363.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current and future directions in medical

Current and future directions in medical therapy for breast carcinoma : Endocrine treatment

✍ Kathleen I. Pritchard 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

The role of antibiotic and probiotic the

The role of antibiotic and probiotic therapies in current and future management of inflammatory Bowel disease

✍ Julia B. Ewaschuk; Qassim Z. Tejpar; Isaac Soo; Karen L. Madsen; Richard N. Fedo 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 171 KB

Medical therapies for the management of

Medical therapies for the management of cardiomyopathy and chronic congestive heart failure

✍ Deborah Meyers 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 345 KB

Review article: future therapies for man

Review article: future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumours

✍ R. SRIRAJASKANTHAN; C. TOUMPANAKIS; T. MEYER; M. E. CAPLIN 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Radiation therapy in the management of m

Radiation therapy in the management of medically inoperable carcinoma of the lungs: Results and implications for future treatment strategies

✍ Daniel E. Dosoretz; Michael J. Katin; Peter H. Blitzer; James H. Rubenstein; Sha 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 937 KB

Current and future status of adjuvant th

Current and future status of adjuvant therapy for breast cancer

✍ Robert E. Coleman 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

Adjuvant systemic treatments have greatly improved the prognosis of women with early breast cancer. Combination chemotherapy and, for patients with oestrogen receptor-positive (ER+) tumours, endocrine treatment has been found to reduce the frequency of relapse and improve survival. New adjuvant stra